These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9762413)

  • 41. Aminopeptidase resistant Arg-Gly-Asp analogs are stable in plasma and inhibit platelet aggregation.
    Fok KF; Panzer-Knodle SG; Nicholson NS; Tjoeng FS; Feigen LP; Adams SP
    Int J Pept Protein Res; 1991 Aug; 38(2):124-30. PubMed ID: 1783488
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-autolysis of trypsin by modification of autolytic site Arg117.
    Li XF; Nie X; Tang JG
    Biochem Biophys Res Commun; 1998 Sep; 250(2):235-9. PubMed ID: 9753613
    [TBL] [Abstract][Full Text] [Related]  

  • 43. RGD-containing peptides inhibit adhesion of 293 cells transfected with GpIIb/IIIa to fibrinogen: comparison to inhibition of platelet aggregation.
    Fei DT; Lowe J; Bodary S; Bunting S; McLean JW; Napier M; Chen AB
    Blood Coagul Fibrinolysis; 1993 Apr; 4(2):255-62. PubMed ID: 8499563
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potent inhibitors of platelet aggregation based upon the Arg-Gly-Asp-Phe sequence of fibrinogen. A proposal on the nature of the binding interaction between the Asp-carboxylate of RGDX mimetics and the platelet GP IIb-IIIa receptor.
    Zablocki JA; Miyano M; Rao SN; Panzer-Knodle S; Nicholson N; Feigen L
    J Med Chem; 1992 Dec; 35(26):4914-7. PubMed ID: 1479591
    [No Abstract]   [Full Text] [Related]  

  • 45. Peptidyl antithrombogenic agents for extracorporeal blood circulation.
    Ito S; Matsuda T; Takemoto Y; Yamamoto K; Kishimoto T; Maekawa M
    Int J Artif Organs; 1992 Dec; 15(12):737-45. PubMed ID: 1493949
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The structure-antiaggregative activity relationship in a series of Arg-Gly-Asp analogs].
    Mel'nik OV; Martinovich VP; Golubovich VP
    Bioorg Khim; 2006; 32(2):137-43. PubMed ID: 16637284
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preparation of peptide-carrying microspheres with bioactivity on platelets.
    Kasuya Y; Fujimoto K; Miyamoto M; Juji T; Otaka A; Funakoshi S; Fujii N; Kawaguchi H
    J Biomater Sci Polym Ed; 1993; 4(4):369-80. PubMed ID: 8373751
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Decompression inducible platelet aggregation (DIPA) is inhibited by Arg-Gly-Asp.
    Murayama M
    Prog Clin Biol Res; 1988; 283():203-9. PubMed ID: 3211951
    [No Abstract]   [Full Text] [Related]  

  • 49. FcgammaRII mediates platelet aggregation caused by disintegrins and GPIIb/IIIa monoclonal antibody, AP2.
    Huang TF; Chang CH; Ho PL; Chung CH
    Exp Hematol; 2008 Dec; 36(12):1704-13. PubMed ID: 18809237
    [TBL] [Abstract][Full Text] [Related]  

  • 50. KRDS, a new peptide derived from human lactotransferrin, inhibits platelet aggregation and release reaction.
    Mazoyer E; Lévy-Toledano S; Rendu F; Hermant L; Lu H; Fiat AM; Jollès P; Caen J
    Eur J Biochem; 1990 Nov; 194(1):43-9. PubMed ID: 2174781
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of platelet adhesion to surfaces of extracorporeal circuits by disintegrins. RGD-containing peptides from viper venoms.
    Musial J; Niewiarowski S; Rucinski B; Stewart GJ; Cook JJ; Williams JA; Edmunds LH
    Circulation; 1990 Jul; 82(1):261-73. PubMed ID: 2364514
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Substitutions of proline 42 to alanine and methionine 46 to asparagine around the RGD domain of the neurotoxin dendroaspin alter its preferential antagonism to that resembling the disintegrin elegantin.
    Lu X; Rahman S; Kakkar VV; Authi KS
    J Biol Chem; 1996 Jan; 271(1):289-94. PubMed ID: 8550575
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design and Synthesis of Non-peptide RGD Mimics for Evaluation of Their Utility as Anti-platelet Agents.
    Higuchi K; Hikita H; Murayama A; Yuri D; Kobayakawa N; Takahashi T; Kojima S; Ueno H; Hatakeyama T; Kato A; Tayu M; Oyama E; Sugiyama S; Ishii K; Takahashi H; Kawasaki T
    Chem Pharm Bull (Tokyo); 2016; 64(12):1726-1738. PubMed ID: 27904082
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Crystal structure of trimestatin, a disintegrin containing a cell adhesion recognition motif RGD.
    Fujii Y; Okuda D; Fujimoto Z; Horii K; Morita T; Mizuno H
    J Mol Biol; 2003 Oct; 332(5):1115-22. PubMed ID: 14499613
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthetic RGD peptides derived from the adhesive domains of snake-venom proteins: evaluation as inhibitors of platelet aggregation.
    Lu X; Deadman JJ; Williams JA; Kakkar VV; Rahman S
    Biochem J; 1993 Nov; 296 ( Pt 1)(Pt 1):21-4. PubMed ID: 8250845
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A novel Arg-Gly-Asp containing peptide specific for platelet aggregation and its effect on tumor metastasis: a possible mechanism of RGD peptide-mediated inhibition of tumor metastasis.
    Isoai A; Ueno Y; Giga-Hama Y; Goto H; Kumagai H
    Cancer Lett; 1992 Aug; 65(3):259-64. PubMed ID: 1381272
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro characterization of a multifunctional staphylokinase variant with reduced reocclusion, produced from salt inducible E. coli GJ1158.
    Pulicherla KK; Kumar A; Gadupudi GS; Kotra SR; Rao KR
    Biomed Res Int; 2013; 2013():297305. PubMed ID: 23998121
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Positional importance of Pro53 adjacent to the Arg49-Gly50-Asp51 sequence of rhodostomin in binding to integrin alphaIIbbeta3.
    Chang CP; Chang JC; Chang HH; Tsai WJ; Lo SJ
    Biochem J; 2001 Jul; 357(Pt 1):57-64. PubMed ID: 11415436
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of retinal pigment epithelial cell-induced tractional retinal detachment by disintegrins, a group of Arg-Gly-Asp-containing peptides from viper venom.
    Yang CH; Huang TF; Liu KR; Chen MS; Hung PT
    Invest Ophthalmol Vis Sci; 1996 Apr; 37(5):843-54. PubMed ID: 8603869
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modulation of RGD sequence motifs regulates disintegrin recognition of alphaIIb beta3 and alpha5 beta1 integrin complexes. Replacement of elegantin alanine-50 with proline, N-terminal to the RGD sequence, diminishes recognition of the alpha5 beta1 complex with restoration induced by Mn2+ cation.
    Rahman S; Aitken A; Flynn G; Formstone C; Savidge GF
    Biochem J; 1998 Oct; 335 ( Pt 2)(Pt 2):247-57. PubMed ID: 9761721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.